Prenylamine: Difference between revisions

	WikiDoc Resources for Prenylamine
Articles
Most recent articles on Prenylamine Most cited articles on Prenylamine Review articles on Prenylamine Articles on Prenylamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Prenylamine Images of Prenylamine Photos of Prenylamine Podcasts & MP3s on Prenylamine Videos on Prenylamine
Evidence Based Medicine
Cochrane Collaboration on Prenylamine Bandolier on Prenylamine TRIP on Prenylamine
Clinical Trials
Ongoing Trials on Prenylamine at Clinical Trials.gov Trial results on Prenylamine Clinical Trials on Prenylamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Prenylamine NICE Guidance on Prenylamine NHS PRODIGY Guidance FDA on Prenylamine CDC on Prenylamine
Books
Books on Prenylamine
News
Prenylamine in the news Be alerted to news on Prenylamine News trends on Prenylamine
Commentary
Blogs on Prenylamine
Definitions
Definitions of Prenylamine
Patient Resources / Community
Patient resources on Prenylamine Discussion groups on Prenylamine Patient Handouts on Prenylamine Directions to Hospitals Treating Prenylamine Risk calculators and risk factors for Prenylamine
Healthcare Provider Resources
Symptoms of Prenylamine Causes & Risk Factors for Prenylamine Diagnostic studies for Prenylamine Treatment of Prenylamine
Continuing Medical Education (CME)
CME Programs on Prenylamine
International
Prenylamine en Espanol Prenylamine en Francais
Business
Prenylamine in the Marketplace Patents on Prenylamine
Experimental / Informatics
List of terms related to Prenylamine

Prenylamine
Clinical data
ATC code	C01DX02 (WHO) ;
Identifiers
	IUPAC name 3,3-Di(phenyl)-N-(1-phenylpropan-2-yl)propan-1-amine;
PubChem CID	9801;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C24H27N
Molar mass	329.48 g/mol

VisualWikitext

Latest revision as of 16:59, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Prenylamine (Segontin) is a calcium channel blocker of the amphetamine chemical class which is used as a vasodilator in the treatment of angina pectoris. It has been shown to partially metabolize to amphetamine and can cause false positives for it in drug tests.^[1]^[2]^[3] Prenylamine also appears to act as a vesicular monoamine transporter inhibitor, and has been demonstrated to deplete vesicular monoamine neurotransmitter stores similarly to reserpine.^[4]

References

↑ Kraemer T, Roditis SK, Peters FT, Maurer HH (March 2003). "Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS". Journal of Analytical Toxicology. 27 (2): 68–73. doi:10.1093/jat/27.2.68. PMID 12669999.
↑ Musshoff F (February 2000). "Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine". Drug Metabolism Reviews. 32 (1): 15–44. doi:10.1081/DMR-100100562. PMID 10711406.
↑ Cody JT (May 2002). "Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results". Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 44 (5): 435–50. doi:10.1097/00043764-200205000-00012. PMID 12024689.
↑ Bagchi SP (1990). "Antidopaminergic action of verapamil and several other drugs: inactivation of vesicular dopamine". Life Sciences. 46 (12): 857–63. doi:10.1016/0024-3205(90)90115-8. PMID 1969603.

[pmid12669999-1] Kraemer T, Roditis SK, Peters FT, Maurer HH (March 2003). "Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS". Journal of Analytical Toxicology. 27 (2): 68–73. doi:10.1093/jat/27.2.68. PMID 12669999.

[pmid10711406-2] Musshoff F (February 2000). "Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine". Drug Metabolism Reviews. 32 (1): 15–44. doi:10.1081/DMR-100100562. PMID 10711406.

[pmid12024689-3] Cody JT (May 2002). "Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results". Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 44 (5): 435–50. doi:10.1097/00043764-200205000-00012. PMID 12024689.

[pmid1969603-4] Bagchi SP (1990). "Antidopaminergic action of verapamil and several other drugs: inactivation of vesicular dopamine". Life Sciences. 46 (12): 857–63. doi:10.1016/0024-3205(90)90115-8. PMID 1969603.

[1]

[2]

[3]

[4]

@@ Line 24: / Line 24: @@
 | routes_of_administration =
 }}
+__NOTOC__
+{{SI}}
 {{CMG}}
@@ Line 35: / Line 36: @@
 {{Vasodilators used in cardiac diseases}}
-[[Category:Aromatic compounds]]
-[[Category:Amines]]
 [[Category:Vasodilators]]
 [[Category:Cardiovascular Drugs]]
-[[Category:Drugs]]
+[[Category:Drug]]
-{{WH}}
-{{WS}}

v t e Vasodilators used in cardiac diseases (C01D)
Nitrates	Glyceryl trinitrate • Isosorbide dinitrate • Isosorbide mononitrate • Molsidomine • Pentaerythritol tetranitrate
Quinolone vasodilators	Flosequinan
Others	Itramin tosilate • Prenylamine • Oxyfedrine • Benziodarone • Carbocromen • Hexobendine • Etafenone • Heptaminol • Imolamine • Dilazep • Trapidil • Molsidomine • Efloxate • Cinepazet • Cloridarol • Nicorandil • Linsidomine • Nesiritide • Gapicomine

Clinical data

ATC code	C01DX02 (WHO)
Identifiers
IUPAC name 3,3-Di(phenyl)-N-(1-phenylpropan-2-yl)propan-1-amine
PubChem CID	9801
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₄H₂₇N
Molar mass	329.48 g/mol

Prenylamine: Difference between revisions

Latest revision as of 16:59, 20 August 2015

Overview

References

Navigation menu